Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys.
暂无分享,去创建一个
T. Parry | L. Sekut | Guoxian Chen | B. Osborn | Marta Corcoran | B. Sturm | Donald Mather | C. Poortman | H. L. Lin
[1] B. Silverman,et al. A Long-Acting Human Growth Hormone (Nutropin Depot®): Efficacy and Safety Following Two Years of Treatment in Children with Growth Hormone Deficiency , 2002, Journal of pediatric endocrinology & metabolism : JPEM.
[2] B. Silverman,et al. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency. , 2001, The Journal of clinical endocrinology and metabolism.
[3] C. Gravholt,et al. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults. , 2001, The Journal of clinical endocrinology and metabolism.
[4] R. Baxter,et al. Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients. , 2000, The Journal of clinical endocrinology and metabolism.
[5] N. Skakkebaek,et al. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. , 2000, The Journal of clinical endocrinology and metabolism.
[6] Evans,et al. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners , 2000, Clinical endocrinology.
[7] M. Vance,et al. Growth hormone therapy in adults and children. , 1999, The New England journal of medicine.
[8] T. Peters,et al. All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .
[9] P. Tapanainen,et al. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats. , 1994, Endocrinology.
[10] 김선우,et al. 갑상선 질환에서 갑상선자극호르몬 결합억제 면역글로불린 측정의 의의 및 그 생성장소에 관한 연구 , 1986 .